Varonis (VRNS) CFO Executes 10b5-1 Sale, Retains 417,497 Shares
Rhea-AI Filing Summary
Guy Melamed, Chief Financial Officer and Chief Operating Officer of Varonis Systems, Inc. (VRNS), reported the sale of 10,400 shares of Varonis common stock on 08/22/2025. The shares were sold under a Rule 10b5-1 trading plan adopted in 2024 at a weighted-average price of $59.53 per share, with transaction prices ranging from $59.50 to $59.57. After the sale, Melamed beneficially owned 417,497 shares. The Form 4 was submitted and signed by an attorney-in-fact on 08/26/2025. The filer notes willingness to provide detailed per-price sale data upon request.
Positive
- Sale executed under a Rule 10b5-1 plan, indicating pre-established trading and compliance with insider trading rules
- Substantial post-sale ownership remains: 417,497 shares, maintaining significant alignment with shareholders
- Disclosure includes weighted-average price and price range and offers detailed per-trade information on request, enhancing transparency
Negative
- Insider reduced holdings by 10,400 shares, which may be viewed negatively by some investors
- Sale price reflects realized liquidity at $59.53 weighted average, potentially signaling management chose to monetize at current levels
Insights
TL;DR Insider sale of 10,400 shares under a pre-established 10b5-1 plan; sizeable remaining ownership.
Melamed's sale was executed under an existing Rule 10b5-1 plan, which typically signals pre-planned, non-discretionary trading rather than opportunistic timing by management. The reported weighted-average sale price of $59.53 and the post-sale ownership of 417,497 shares indicate the executive retains significant economic exposure to VRNS. For investors, this is a routine liquidity event by an officer rather than a clear signal of changed company prospects.
TL;DR Sale follows compliant governance practices; disclosure is appropriately transparent.
The disclosure states the sale was pursuant to a 10b5-1 plan adopted in 2024 and provides a weighted-average price plus a range of execution prices, with an offer to supply detailed per-trade prices on request. Filing signatures and use of an attorney-in-fact are documented. These elements reflect adherence to standard insider trading disclosure and plan usage practices, supporting transparency and compliance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, par value $0.001 per share | 10,400 | $59.53 | $619K |
Footnotes (1)
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.50 to $59.57, inclusive. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer, or a shareholder of the Issuer full information regarding the number of shares sold at each separate price.
